Skip to content

The Effect of Rhythmic Auditory Stimulation on Gait in Chronic Stroke Patients

The Effect of Rhythmic Auditory Stimulation Tempo Shifts Application on Gait Parameters in Chronic Stroke Patients: A Pilot Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
LBCTR
Registry ID
LBCTR2021024744
Enrollment
30
Registered
2021-02-14
Start date
2021-01-04
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition: Chronic Stroke Patients (Hemiplegia) Problems Studied: Gait (spatio-temporal parameters)/ Walking Issues/ Motor Issues/ Impairment/ Function stroke/ hemi/ gait/ function/ RAS

Interventions

Each participant will walk along a wide unobstructed 10-m walkway at preferred speed with the possibility to use a uniform walking aid when needed, based on this each participant’s cadence will be cal
weight shifting while in sitting and standing, transfers from sitting to standing, and from one chair to another (with and without arm support) as well as enhancing static balance
while sitting and standing in addition to management of the upper extremity
through stretching, range of motion exercises of high repetition, and functional reaching exercises.
Rhythmic Auditory Stimulation is a neurologic technique used to facilitate the rehabilitation of movements that are intrinsically biologically rhythmical, most importantly gait. RAS uses the physiolog

Sponsors

Farah Ayoubi
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were as follows: 1) able to walk for a 10-m distance. 2) Able to follow instructions. 3) Doesn’t suffer from cognitive impairment with a Modified Mini Mental State Examination (3MS) score of 79 or higher. 4) Brunnstrom recovery scale of stages (4-6).

Exclusion criteria

Exclusion criteria: Individuals were excluded if any demonstrated one or more of the following conditions: 1) Auditory or visual problems. 2) Chronic pain and/or an orthopedic condition which affects gait. 3) Symptomatic cardiac failure. 4) Neurologic condition other than initial stroke. 5) Major depression or psychological issues.

Design outcomes

Primary

MeasureTime frame
Name: Angle measurements;Timepoints: At session 1 and session 12;Measure: Angles in degrees via Kinovea software;Name: Angle symmetry;Timepoints: At session 1 and session 12;Measure: SI (symmetry index);Name: Velocity;Timepoints: At session 1 and session 12;Measure: 10m walk test;Name: Cadence;Timepoints: At session 1 and session 12;Measure: Number of steps/min using pedometer;Name: Step Length;Timepoints: At session 1 and session 12;Measure: Steps in cm using kinovea software

Secondary

MeasureTime frame
Name: Cognition (pre-requisite to enrollment);Timepoints: At session 1 (pre-experiment);Measure: 3MS (Modified Mini Mental State examination);Name: Muscular strength/ Motor ability (global);Timepoints: At session 1 (pre-experiment);Measure: Brunnstrom scale

Countries

Lebanon

Contacts

Public ContactFarah AYOUBI

Research Advisor/ Supervisor / Research Instructor/ MPT/ PhD/ PT at Antonine University

farah.ayoubi@ua .edu.lb71765367

Outcome results

None listed

Source: LBCTR (via WHO ICTRP) · Data processed: Feb 7, 2026